Joseph K. Belanoff
2007
In 2007, Joseph K. Belanoff earned a total compensation of $1.6M as Chief Executive Officer at Corcept Therapeutics, a 316% increase compared to previous year.
Compensation breakdown
| Bonus | $102,752 |
|---|---|
| Option Awards | $1,130,000 |
| Salary | $411,008 |
| Total | $1,643,760 |
Belanoff received $1.1M in option awards, accounting for 69% of the total pay in 2007.
Belanoff also received $102.8K in bonus and $411K in salary.
Rankings
In 2007, Joseph K. Belanoff's compensation ranked 2,761st out of 8,700 executives tracked by ExecPay. In other words, Belanoff earned more than 68.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,761 out of 8,700 | 68th |
Division Manufacturing | 951 out of 3,314 | 71st |
Major group Chemicals And Allied Products | 186 out of 746 | 75th |
Industry group Drugs | 100 out of 546 | 82nd |
Industry Pharmaceutical Preparations | 77 out of 364 | 79th |
Source: SEC filing on May 17, 2010.
Belanoff's colleagues
We found three more compensation records of executives who worked with Joseph K. Belanoff at Corcept Therapeutics in 2007.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019